SGHT
Sight Sciences, Inc. · Healthcare
Director and 10% owner Staffan Encrantz bought $452K of Sight Sciences, Inc.
Bought$451,734
$3.52Price
128,189Shares
+2%Stake
What SGHT did for a copier
- $1,000 copied at Fri, May 30 open, $3.65
- $915
- S&P 500, same days
- +6.0%
Measured over 30 trading days, to the Jul 15 close.
Staffan Encrantz's record
8 other buys with 3 months of prices since 2021: on average −7.4% against the S&P 500, and 2 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, May 27. Filed Thu, May 29, 9:31 PM ET, after the close. Returns use the May 30 open and the Jul 15 close. Not investment advice.